Navigation Links
XTL to Present at the Arch Investment Conference
Date:9/5/2007

VALLEY COTTAGE, New York, September 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and hepatitis C, today announced today that Ron Bentsur, the Company's Chief Executive Officer, is scheduled to present at the Arch Investment Conference. Mr. Bentsur will present an overview of the Company including a discussion of Bicifadine, the Company's late-stage clinical compound for the treatment of neuropathic pain. Mr. Bentsur's presentation will take place, tomorrow, Thursday, September 6, 2007 at 11:30 pm Eastern Daylight Time, at the Warwick Hotel in New York City.

A live audio webcast of Mr. Bentsur's presentation will be available at: http://www.informedinvestors.com/VC/ClientPage.asp?ID=45356. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT XTL BIOPHARMACEUTICALS LTD.

XTL Biopharmaceuticals Ltd. ("XTL") is engaged in the development of therapeutics for the treatment of neuropathic pain and hepatitis C. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of diabetic neuropathic pain. XTL is also developing several novel pre-clinical hepatitis C small molecule inhibitors. XTL also has an active in-licensing and acquisition program designed to identify and acquire additional drug candidates. XTL is publicly traded on the NASDAQ, London, and Tel-Aviv Stock Exchanges (NASDAQ: '/>"/>

SOURCE XTL Biopharmaceuticals Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... to Special Protocol Assessment with the Food ... 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... a global biopharmaceutical company focused on oncology ... by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ... clinical trial for perifosine (KRX-0401), the Company,s ...
(Date:12/16/2009)... Filtration and Separations Society will hold its 23rd Annual Technical Conference ... in San Antonio, Texas. To further impact the separation society and ... proud to announce that the 2010 AFS Annual Technical Conference will ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- The ...
(Date:12/15/2009)... China, Dec. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... Republic of China ("PRC"), today,announced that the Company ... the 2009,Edition of the National Basic Medical Insurance, ... The 30 medicines treat ...
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and are ... the liquid/air interface. The NeedleProbes’ cylindrical geometry enables researchers ... and viscosity - all in a single force distance curve. ... ... -- New, constant diameter NeedleProbes are enabling unique ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3
... with potential Benitec HIV therapy, MELBOURNE, Australia, Aug ... of Understanding with California-based,CalbaTech, Inc. (OTC Bulletin Board: CLBE) ... who may use the healthy adult (or "blood" or,"hematopoietic") ... with City of Hope, a biomedical research and,treatment center, ...
... Avicena Group,Inc. (OTC Bulletin Board: AVGO), a late-stage ... neurodegenerative diseases,announced today that Chief Executive Officer Dr. ... ongoing product development,programs at 1:30 EDT on August ... at the Charleston Place Hotel in Charleston, S.C. ...
... Number and Viability of Stem Cells Derived from ... Patented Preservation Media, BOTHELL, Wash., Aug. 17 ... and marketer of,proprietary hypothermic storage and cryopreservation media products ... the exclusive,supplier of preservation media to the New England ...
Other Biology Technology:Benitec MOU With CalbaTech, Inc. 2Benitec MOU With CalbaTech, Inc. 3Benitec MOU With CalbaTech, Inc. 4Avicena Group to Present at Noble Financial Conference 2BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc. 2BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc. 3
(Date:12/16/2009)... 8, 2009 National Instruments (Nasdaq: ... measurement and control, and DENSO Robotics, a ... robotics technology, today announced their collaboration to ... DENSO robotic arms. The collaboration increases productivity ... flexible manufacturing applications. In today,s trend toward ...
(Date:12/16/2009)... CHURCH, Va., Dec. 9 CSC ... that the American Association for Laboratory Accreditation ... Commission (ISO/IEC) 17025:2005 accreditation to the company,s ... CSC Identity Labs located in Fairmont, W.Va. ... test laboratory in the world to achieve ...
(Date:12/15/2009)... The 2009 Frost & Sullivan European Border ... Sagem Securite (Safran Group) for its innovative ... the company,s expertise in advanced biometric technology ... value-added products to end users. ,, ... Securite has been involved in delivering identification ...
Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Benevolence Beyond Politics Inc Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide 6372 1Benevolence Beyond Politics Inc Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide 6372 2Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 1Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 2Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 3Merz Pharmaceuticals Announces Approval of Post stroke Upper Limb Spasticity Indication for Xeomin 28R 29 in the EU 6368 4Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 1Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 2Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 3Results From Two Phase II Trials Add to Understanding of Ticagrelor 28BRILINTA 28TM 29 29 and How it Works in the Body 6364 4
... tomatoes to grow purple tomatoes high in health-protecting ... at particularly high levels in berries such as ... to increase the levels of health-promoting compounds in ... people do not eat 5 portions of fruits ...
... Rockot launcher that shall carry ESA,s GOCE Earth Explorer ... failure in the guidance and navigation system of the ... discovered during the spacecraft,s launch preparation tests on 7 ... postponement of the launch. , The cause of the ...
... Researchers at the Heidelberg University Hospital have discovered a new ... a protective component of the bile is missing, the liver ... resulting in cirrhosis of liver, a transformation of liver cells ... This could explain some of the cases of liver cirrhosis ...
Other Biology News:Fried purple tomatoes 2Toxic bile damages the liver 2
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
... cells were cultured in RPMI 1640 with 2 ... of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on ... each wells surface specifically treated to enhance cellular ...
...
Mouse monoclonal [H4B4] to LAMP2 - Lysosome Marker (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 3920 SwissProtID: P13473...
Biology Products: